Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A "Game Changer" for Prostate Treatment?

Citation data:

International journal of radiation oncology, biology, physics, ISSN: 1879-355X, Vol: 100, Issue: 2, Page: 361-373

Publication Year:
2018
Captures 38
Readers 38
Mentions 2
Blog Mentions 1
News Mentions 1
Social Media 278
Shares, Likes & Comments 173
Tweets 105
Citations 7
Citation Indexes 7
PMID:
29353654
DOI:
10.1016/j.ijrobp.2017.10.020
Author(s):
Pathmanathan, Angela U; van As, Nicholas J; Kerkmeijer, Linda G W; Christodouleas, John; Lawton, Colleen A F; Vesprini, Danny; van der Heide, Uulke A; Frank, Steven J; Nill, Simeon; Oelfke, Uwe; van Herk, Marcel; Li, X Allen; Mittauer, Kathryn; Ritter, Mark; Choudhury, Ananya; Tree, Alison C Show More Hide
Publisher(s):
Elsevier BV
Tags:
Physics and Astronomy; Medicine; Biochemistry, Genetics and Molecular Biology
Most Recent Tweet View All Tweets
Most Recent Blog Mention
Most Recent News Mention
review description
Radiation therapy to the prostate involves increasingly sophisticated delivery techniques and changing fractionation schedules. With a low estimated α/β ratio, a larger dose per fraction would be beneficial, with moderate fractionation schedules rapidly becoming a standard of care. The integration of a magnetic resonance imaging (MRI) scanner and linear accelerator allows for accurate soft tissue tracking with the capacity to replan for the anatomy of the day. Extreme hypofractionation schedules become a possibility using the potentially automated steps of autosegmentation, MRI-only workflow, and real-time adaptive planning. The present report reviews the steps involved in hypofractionated adaptive MRI-guided prostate radiation therapy and addresses the challenges for implementation.